interval of 23 deafness loci. Reanalysis of unassigned ESTs from the prior study revealed 338 additional To identify genes involved in hearing, 8494 expressed known human genes. The total number of known sequence tags (ESTs) were generated from a human human genes identified from 8494 cochlear ESTs is fetal cochlear cDNA library in two distinct sequencing 1449 and is represented by 4040 ESTs. Among the projects. Analysis of the first set of 4304 ESTs revealed known human genes are 14 deafness-associated genes, clones representing 517 known human genes, 41 mamincluding GJB2 (connexin 26) and KVLQT1. The total malian genes not previously detected in human tissues, number of nonhuman mammalian genes identified is 487 ESTs from other human tissues, and 541 cochlear-43 and is represented by 58 ESTs. The total number specific ESTs (http://hearing.bwh.harvard.edu). We of ESTs without sequence similarity to known genes is now report results of a DNA sequence similarity 4055. Of these, 778 also do not have sequence similar-(BLAST) analysis of an additional 4190 cochlear ESTs ity to any other ESTs, are categorized into 700 clusters, and a comparison to the first set. Among the 4190 and may represent genes uniquely or preferentially new cochlear ESTs, 959 known human genes were expressed in the cochlea. Identification of additional identified; 594 were found only among the new ESTs known genes, ESTs, and cochlear-specific ESTs proand 365 were found among ESTs from both sequencvides new candidate genes for both syndromic and ing projects. COL1A2 was the most abundant transcript nonsyndromic deafness disorders. among both sets of ESTs, followed in order by COL3A1,
INTRODUCTION
cochlear ESTs and revealed 318 additional loci. Fortynine of the mapped ESTs are located within the genetic Hearing loss is the most frequent sensory defect in humans. The prevalence of severe to profound bilatAbbreviations: basic local alignment search tool (BLAST), expressed eral congenital hearing loss is estimated at 1 in 1000 sequence tag (EST), sequence tagged site (STS), sequence produced from 5Ј end of insert (5Ј read), sequence produced from 3Ј end of births (Gorlin et al. 1995) . About 50% of congenital insert (3Ј read) deafness is thought to be due to environmental factors, terial infections (e.g., bacterial meningitis). The remaining 50% is attributed to genetic causes and is vector (Stratagene, La Jolla, CA). The first set of 4304 ESTs were analyzed previously (Skvorak et al. 1999 ) categorized as syndromic or nonsyndromic hearing loss. Approximately 77% of hereditary deafness is estiand have GenBank accession numbers starting with either of the letters H or N. For generation of the mated to be inherited in an autosomal recessive mode, 22% is autosomal dominant, 1% is X-linked, and less second set of 4190 ESTs, a second aliquot of the human fetal cochlear cDNA library was subjected to mass in than 1% segregates through the maternal lineage via the mitochondria (Morton 1991) . Over 400 syndromes vivo excision according to the manufacturer's protocol to remove phage sequences. Gridding of the clones are recognized in which hearing loss is among the clinical findings and over 60 loci have been mapped was performed at Lawrence Livermore National Laboratory. Sequencing of the 5Ј ends of the inserts using for nonsyndromic hearing loss (Gorlin et al. 1995; Van Camp and Smith 2001) . At least 46 genes known to a T7 primer (5Ј TAATACGACTCACTATAGGG 3Ј) and generation of the ESTs, as described previously cause either syndromic or nonsyndromic deafness have been identified to date (Steel and Kros 2001; Van (Skvorak et al. 1999) , was performed at the NIH Intramural Sequencing Center. GenBank accession numCamp and Smith 2001).
Traditional methods for identification of genes bers for the second cochlear ESTs start with the letters AW. involved in disease, such as genetic linkage analysis, have a less than optimal use in gene discovery efforts for hearing disorders, mainly because of the complex EST nucleotide sequence analysis genetic nature of deafness. Although more than 60 disease loci for nonsyndromic deafness are known, the To obtain the data described here, the nucleotide sequence of each cochlear EST was used to conduct number of disease loci is expected to be considerably larger due to the unparalleled degree of genetic hetersequence similarity (BLAST) searches against various databases (Altschul et al. 1997) . EST sequences were ogeneity that characterizes hereditary deafness (Van Camp et al. 1997 al. 1984; Jones and Reed 1989; Gurish et al. 1992) . To this end, we constructed a human fetal cochlear cDNA tide similarity with known sequences, as previously described (Skvorak et al. 1999) . Briefly, a cochlear EST library and have generated over 8494 ESTs in two sequencing projects from the cochlear cDNA clones sequence was considered to be a significant match to a nucleotide sequence when E Ͻ 1E Ϫ 30, the aligned (Robertson et al. 1994; Skvorak et al. 1999) . Several auditory genes, namely ATQ1, COCH, and OTOR, of region was Ͼ50 nucleotides, and the nucleotide identify was Ͼ85% over the aligned region, or E Ͻ 1E Ϫ which the latter two are novel cochlear genes, have been identified using our human fetal cochlear cDNA 20, the aligned region was Ͼ50 nucleotides, and the nucleotide identity was Ͼ90% over the aligned region. library (Robertson et al. 1997 (Robertson et al. , 2000 Skvorak et al. 1997) . COCH was further shown to be responsible for a
The E value is the Expect value; it describes the number of hits one can expect by chance alone when sensorineural deafness and vestibular disorder, DFNA9 (Robertson et al. 1998) .
searching a database of a particular size (Altschul et al. 1997) . The majority of cochlear EST sequences that This article describes the production and analysis of the second set of 4190 cochlear EST sequences and identified human genes were Ͼ95% identical to the nucleotide sequence. If a BLAST search revealed a compares these results with that of the first set of 4304 cochlear ESTs. significant match to more than one hit, only the highest scoring hit was included in the data set. Any cochlear EST sequences that did not have sequence similarity to any known human or nonhuman genes
METHODS
or EST sequences from other cDNA libraries were considered cochlear-specific, with the caveat that this
Generation of EST sequences from the human categorization is dependent on the diversity and comfetal cochlear cDNA library pleteness of transcripts deposited in the public databases at the time of analysis. A human fetal (16-22 weeks developmental age) cochlear cDNA library was constructed by Robertson et al. (1994) Redundancy among cochlear ESTs from the two sequencing projects was determined by comparing the and were directionally cloned into the Uni-ZAP XR nucleotide sequence of each new cochlear EST with similarly over entire EST sequence, n ϭ 68) (Table 1) . the nucleotide sequence of the cochlear ESTs from Of note, the 68 cochlear ESTs with Ͼ95% similarity project 1 and identifying those ESTs with nucleotide to yeast genes have been deleted from GenBank. In sequence similarity, as determined by the same criteria sum, 186 ESTs were omitted from the present analysis; as above for BLAST analysis. Of note, ESTs from the 4004 (95.5%) new cochlear ESTs were included in second sequencing project were generated from the this analysis and represent the denominator for the 5Ј ends of the cDNA clones, in contrast to the first statistical analyses. sequencing effort, in which one-third were generated from the 5Ј ends of the cDNA inserts and two-thirds from the 3Ј ends.
Identification of known genes in the cochlear library
Assignment of ESTs to chromosomal map
Of the 4004 new cochlear ESTs, 2050 (51%) were positions assigned to 959 known human genes ( Table 2) . 365 (38%) of these genes, represented by 1279 (32%) of A cochlear EST was considered mapped when it had the new cochlear ESTs, had been identified among nucleotide sequence similarity to an STS according to the ESTs from project 1 and thus represent genes the criteria described above (E values, identity) and identified by both sequencing efforts ( Fig. 1 ). Examthe STS had a chromosomal assignment. In the majorples of genes found in both analyses are collagen type I ity of cases, the EST sequence matched the STS alpha 2 (COL1A2), collagen type III alpha 1 (COL3A1), sequence with Ͻ95% identity. To determine the chroelongation factor 1 alpha (EEF1A1), and SPARC (Table  mosomal assignment, marker interval, and genetic 3). These four genes were also some of the most freinterval for a particular STS, the following websites quently detected genes among the ESTs, reflecting were used: Whitehead Institute for Biomedical their abundant expression in the human fetal cochlear Research/MIT Center for Genome Research (http:// library (Table 3) . Genes detected less frequently and www-genome.wi.mit.edu/), the Stanford Human found in common among the two analyses included Genome Center (http://www-shgc.stanford.edu/), the following genes found once among ESTs from NCBI's Query STS Sequence Database (http:// both projects: calpactin 1 light chain, ribosomal prowww2.ncbi.nlm.nih.gov/dbST/dbsts query.html), tein L31, and dynein light chain 1. Of the 959 known and NCBI's UniGene database (http://www.ncbi.nlm.
human genes identified in the second project, 594 nih.gov/UniGene/Hs.Home.html). Some genetic (62%) genes, represented by 771 (19%) ESTs, were intervals may be unknown if fine mapping information identified specifically among the new cochlear ESTs was unavailable for a particular genetic marker. Marker and were not found among the previously analyzed intervals for deafness loci were obtained from the cochlear ESTs (Fig. 1) . 476 of these newly detected Hereditary Hearing Loss home page (Van Camp and genes were found only once and 118 were found more Smith 2001) and their genetic intervals were deterthan once; the most abundant newly detected genes mined by searching the STS database at the Whitehead were initiation factor 4B (n ϭ 10), ribosomal protein Institute/MIT's website as listed above.
S24 (n ϭ 6), MHC protein homologous to chicken B complex protein (n ϭ 6), and cyclin I (n ϭ 5). A complete list of the known human genes found among the new cochlear ESTs can be accessed via our website
RESULTS
(http://hearing.bwh.harvard.edu).
Among the 1954 cochlear ESTs not representing a known human gene, 28 ESTs had homology to 22
Production of a second set of human cochlear nonhuman mammalian genes, with nucleotide EST sequences sequence identity ranging from 83% to 96% (Table  4 ). Among these ESTs are genes encoding membrane As a result of the second round of sequencing of clones proteins, extracellular matrix proteins, and trafficking from the Morton human fetal cochlear cDNA library proteins. These cochlear ESTs had homology to genes (see Methods), an additional 4190 human cochlear in species such as cow, mouse, and rat and may repreESTs were deposited in GenBank. Only 186 (4.5%) of sent the human homologs. None of these 22 nonhuthese cochlear EST sequences were found not to be man mammalian genes were identified during project useful for further analysis, either because of insuffi-1, although 41 nonhuman mammalian genes were cient sequence length (i.e., less than 100 bases, n ϭ identified in that effort (20 for which the human 21), repetitive sequence content (i.e., Alu or L1 elements, n ϭ 97), or homology to yeast genes (Ͼ95% homolog has since been identified). 
EST database
GenBank. Of these, 778 ESTs are unique ESTs in Gen-1926 (48%) of the project 2 cochlear ESTs did not Bank, are grouped by nucleotide sequence similarity have significant sequence similarity to any known gene into 700 clusters, and may be considered cochlear- (Table 5 ). Of these, 1568 ESTs represent 1262 clusters specific (Table 5 ). or genes that have sequence similarity to ESTs from other tissue-derived libraries. The remaining 358 ESTs, which are categorized into 333 clusters, did not match
Chromosomal map position of cochlear ESTs
any other ESTs in GenBank and may be unique to the for positional candidate deafness genes cochlear library, suggesting they may represent genes specifically or preferentially expressed in the cochlea.
Nucleotide sequence similarity (BLAST) analysis was performed against the STS database to determine the Of the 333 cochlear-specific clusters, 327 are new and 6 had already been identified by project 1. Combining chromosomal map positions of the 1926 project 2 cochlear ESTs that were not assigned as either a human results from projects 1 (updated) and 2, a total of 4055 (Table 6 ). For example, two new cochlear ESTs, some, 7 ESTs (representing 3 loci) were cochlear-spe-AW022164 and AW022528, map to chromosome 2 cific and were assigned to chromosomes 9, 12, and 17.
within the genetic interval for the nonsyndromic deafThese three loci are identified by the following ESTs: ness disorder DFNA16 (171.9-182.5 cM). The AW023375 (chromosome 9), AW020502 (chromocochlear EST AW023065 maps to chromosome 9 some 12), and AW020266 (chromosome 17).
within the genetic interval of DFNB7 and DFNB11.
(Note: AW023065 is assigned to a cluster consisting of 2 overlapping cochlear ESTs. Because the library was not normalized, the cluster size reflects the relative New cochlear ESTs map to deafness loci level of expression of a particular gene.) Another EST, The map positions of 49 project 2 cochlear ESTs, repre-AW023248, maps to chromosome 10 within the genetic senting 28 distinct loci, fall within the genetic intervals interval for the syndromic deaf/blind disorder USH1F (60.4-77.2 cM). of 23 syndromic and nonsyndromic deafness loci and 72 for contribution of nucleotide sequences that approach, using total RNA extracted from 16-22 week make up novel UniGene entries. human fetal cochlea, was our source for expressed A total of 8494 human cochlear ESTs were generauditory genes. Nucleotide sequence similarity ated from our human fetal cochlear cDNA library, of (BLAST) analysis was performed with various Genwhich 5393 (63.5%) were 5Ј reads and 3097 (36.5%) Bank databases to determine which known human and were 3Ј reads. 8153 (96%) of these ESTs were used novel human homologs of nonhuman mammalian for BLAST analyses. About 50% of these ESTs (n ϭ genes were present among the cochlear ESTs. The 4040) had sequence similarity to a total of 1449 known EST database was also included in the analysis for human genes, of which 365 were identified by ESTs identification of corresponding ESTs from other tisfrom both sequencing projects; 490 genes were identisue-derived libraries. Any cochlear EST that did not fied uniquely by ESTs from project 1, and 594 were have nucleotide sequence similarity to a gene or other identified only by ESTs from project 2. A total of 43 EST was considered to be "cochlear-specific." The human homologs of nonhuman mammalian genes chromosomal map position was determined for those have also been identified. Of the remaining 4055 ESTs, ESTs that did not have significant sequence similarity to any known gene to establish whether a particular 3277 have sequence similarity to other ESTs and repre- sent 2266 clusters or genes. The remaining 778 ESTs Identification of cochlear ESTs that map to deafness loci provide another way to identify genes important have sequence similarity to no known genes nor ESTs and are considered to be "cochlear-specific." for hearing, especially those involved in hearing impairment. All cochlear ESTs mapped on human Identification of cochlear ESTs with significant nucleotide sequence similarity only to known mammachromosomes, including those from project 1, that do not have nucleotide sequence similarity to a known lian genes not found previously in human tissue is important because these cochlear ESTs may represent gene sequence are presented on our website (http:// hearing.bwh.harvard.edu); also included are the the respective human homologs. The nonhuman genes may be characterized already, facilitating both known syndromic and nonsyndromic deafness loci. A total of 788 loci are represented by cochlear ESTs, 318 the cloning and functional assessment of the human homologs, and thus aiding the process of understandof which were identified by the present study. Of the project 2 cochlear ESTs that have nucleotide sequence ing their role in human hearing. Among the group of 43 nonhuman mammalian genes are genes that similarity to no known gene, 373 have been mapped in the human and at least 4 (representing 2 loci) and encode several transmembrane proteins of interest. Transmembrane proteins, such as the connexins, have as many as 39 (representing 36 loci) are found on every chromosome, excluding the Y chromosome. been shown to be important for the hearing process, specifically for maintenance of the potassium-rich Forty-nine of these mapped project 2 ESTs represent 28 distinct genetic loci that are located within the endolymph by actively recycling potassium ions from within hair cells to supporting cells, stria vascularis, genetic intervals of 23 deafness loci. Including the mapped ESTs from project 1, a total of 120 cochlear and back to the endolymph. tissue-specific cDNA libraries). This is not a surprising finding as all of the genes responsible for nonsyn-
